Exact Sciences Corporation (EXAS): Price and Financial Metrics
Exact Sciences Corporation (EXAS)
Today's Latest Price: $106.11 USD
Updated Oct 22 1:33pm
Add EXAS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 58 in Medical - Diagnostics/Research
See all "A" rated Strong Buy stocks
EXAS Stock Summary
- EXAS has a market capitalization of $14,958,166,745 -- more than approximately 88.4% of US stocks.
- EXAS's price/sales ratio is 13.22; that's higher than the P/S ratio of 89.14% of US stocks.
- As for revenue growth, note that EXAS's revenue has grown 81.5% over the past 12 months; that beats the revenue growth of 93.54% of US companies in our set.
- Stocks that are quantitatively similar to EXAS, based on their financial statements, market capitalization, and price volatility, are HZNP, AYX, BL, NTRA, and IRTC.
- EXAS's SEC filings can be seen here. And to visit Exact Sciences Corp's official web site, go to www.exactsciences.com.
EXAS Stock Price Chart Interactive Chart >
EXAS Price/Volume Stats
| Current price | $106.11 | 52-week high | $110.74 |
| Prev. close | $99.61 | 52-week low | $35.25 |
| Day low | $100.00 | Volume | 785,896 |
| Day high | $106.39 | Avg. volume | 1,949,579 |
| 50-day MA | $88.61 | Dividend yield | N/A |
| 200-day MA | $83.93 | Market Cap | 15.93B |
Exact Sciences Corporation (EXAS) Company Bio
Exact Sciences is a molecular diagnostics company focused on gastrointestinal cancers. The company develops the Cologuard, a non-invasive stool-based DNA colorectal cancer screening test that is designed to detect pre-cancerous lesions or polyps, and each of the four stages of colorectal cancer. The company was founded in 1995 and is based in Madison, Wisconsin.
Loading social stream, please wait...